Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC
This clinical trial update reports on an observational study examining the combination of a fluoropyrimidine and bevacizumab in patients wit…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue
This ClinicalTrials.gov entry describes a study on metabolomic pathways and Traditional Chinese Medicine body constitution in cancer-related…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery
An observational study evaluating whether proteomic and physiological parameters can predict postoperative complications after colorectal ca…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MIMICC Study in Patients With Colorectal Cancer [NA]
The MIMICC Study in colorectal cancer is currently recruiting, with conditions including colorectal cancer, colon cancer, and rectal cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
EMA approval · 2026-03-25EMA Authorised: Zirabev (bevacizumab) — Pfizer Europe MA EEIG
Zirabev (bevacizumab) has been authorised by EMA for multiple cancer indications, including colorectal, breast, non-small cell lung, renal c…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
A completed clinical trial evaluating the impact of preoperative sarcopenia on surgical outcomes in colorectal cancer patients.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... [Phase 1, Phase 2]
A Phase I/II clinical trial assessing durvalumab in combination with olaparib and/or cediranib for advanced solid tumors, including colorect…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating a KRAS-specific autologous TCR-T cell therapy for KRAS-mutant advanced solid tumors, including colore…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study of ERAS-007 in patients with advanced gastrointestinal malignancies, sp…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases [Phase 2]
Phase 2 clinical trial SCRT-CAPEOX-Serplulimab for MSS/pMMR rectal cancer with oligometastases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours [Phase 1]
A Phase 1 trial evaluating intratumoral IVX037 in patients with advanced or metastatic solid tumours; the study is currently recruiting, foc…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy [NA]
This item reports a clinical trial update on using plasma multi-omics detection to assess efficacy and recurrence risk in oligometastatic co…
-
EMA approval · 2026-03-24EMA Authorised: Stivarga (regorafenib) — Bayer Pharma AG
The EMA authorised Stivarga (regorafenib) for colorectal cancer (colorectal neoplasms). The decision was issued on 26 February 2026.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial evaluating perioperative systemic therapy for patients with isolated resectable colorectal cancer with perito…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer [Phase 2]
This document describes a Phase 2 clinical trial testing becotatug vedotin in combination with cetuximab for later-line treatment of metasta…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. [Phase 1]
Phase 1 trial evaluating HRO761 alone or in combination in cancer patients with microsatellite instability-high (MSI-H) or mismatch repair d…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study [Phase 1, Phase 2]
A prospective Phase Ib/II trial in colorectal cancer evaluating Fruquintinib with a checkpoint inhibitor, either in combination with TAS-102…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients
This entry reports a terminated clinical trial assessing circulating extracellular vesicles as biomarkers in patients with colorectal cancer…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Colorectal Cancer Screening in Cystic Fibrosis
University of Washington is conducting a study on colorectal cancer screening in people with cystic fibrosis; the trial is currently active …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: BBO-11818 in Adult Subjects With KRAS Mutant Cancer [Phase 1]
Phase 1 trial update for BBO-11818 in adults with KRAS-mutant cancers, currently recruiting across several KRAS-driven solid tumors includin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and preliminary efficacy of GSK5460025 alone or in combination …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.